Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: BHP Falls After Earnings Miss Expectations

Tue, 20th Aug 2019 10:28

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------J Sainsbury, up 2.5%, Ocado Group, up 2.4%. The UK grocery market was flat in the past three months due to "tough" comparatives with last year's hot summer, a survey by Kantar Worldpanel showed. In the 12 weeks to August 11, supermarket sales were flat compared to a year before, Kantar said. Ocado claimed the top spot as the UK's fastest growing grocer, increasing sales by 13% during the period. The online grocer increased its shopper base by 7% and encouraged its customers to spend GBP1.93 more each delivery, Kantar noted. Sainsbury's accounted for 15.4% of all UK supermarket sales during the 12-week period. Overall Sainsbury's sales fell by 0.6%, however, despite sales of branded goods rising by 1.5%, driven by higher levels of promotion and Sainsbury's price lockdown strategy.----------Antofagasta, up 1.9%. Goldman Sachs raised the copper miner to Neutral from Sell. ----------AstraZeneca, up 1.7%. The Anglo-Swedish drugmaker reported positive results from the third phase of the DAPA-HF trial. Astra said the study showed Farxiga met the primary composite endpoint with a reduction of cardiovascular death or the worsening of heart failure, compared to a placebo.----------FTSE 100 - LOSERS----------Rentokil Initial, down 2.0%. RBC Capital cut the pest control company to Sector Perform from Outperform. ----------BHP Group, down 1.0%. The Anglo-Australian miner reported an improvement in performance in its most recently ended financial year, but results were mostly below what the market had expected. For the 12 months to June, the mining giant's pretax profit rose 2.0% to USD15.05 billion the prior year, while underlying earnings before interest, tax, depreciation, and amortisation were broadly flat year-on-year at USD23.16 billion compared to USD23.18 billion. The underlying Ebitda figure fell short of the USD23.71 billion expected by analysts. BHP's annual revenue from continuing operations was USD44.29 billion, up 2.7% from a year earlier, but again below consensus of USD44.74 billion. "The current negative backdrop would suggest BHP may find it hard to keep growing earnings at the current rate, particularly in the short term," noted AJ Bell's Russ Mould. ----------FTSE 250 - WINNERS----------Mitchells & Butlers, up 3.2%. Canaccord upgraded the pub and restaurant operator to Buy from Hold. ----------IMI, up 1.7%. The engineer IMI announced the USD85 million acquisition of Pennsylvania-based valve and flow control product maker PBM. PBM will join IMI's Critical Engineering division, and IMI said the deal is an "important opportunity" to broaden into an "attractive, adjacent market". PBM registered USD6.8 million of adjusted earnings before interest, tax, depreciation, and amortisation in 2018, on revenue of USD35.6 million. By comparison, FTSE 250-listed IMI delivered revenue of GBP1.91 billion.----------FTSE 250 - LOSERS----------Ashmore Group, down 2.8%. Exane BNP cut the emerging markets-focused asset manager to Neutral from Outperform. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Avesoro Resources, up 27% at 87.70p. Shares in the miner climbed after it said its major shareholder is considering a buyout. The firm is also considering a review of the Youga gold mine, and has suspended guidance due to ongoing problems both at Youga and the New Liberty mine. Avesoro Jersey currently owns 73% of Avesoro, and the company has now said a "non-binding expression of interest" has been made to buy the rest of Avesoro's shares at 100 pence each. The company said shareholders owning 13% of Avesoro have already supported the move. Avesoro Jersey is led by Avesoro Non-Executive Chair Murathan Gunal, a Turkish businessman. On the operational front, Avesoro is now assessing the long-term viability of Burkina Faso's Youga gold mine. Last Wednesday night, a security guard at the mine shot dead a clandestine miner at Youga, which led to a break-in by an armed group of fellow artisanal miners. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Mysale Group, down 47% at 2.5p. The online retailer said it intends to raise at least GBP10.0 million before expenses from a share placing. The online retailer said the placing will enable it to repay its bank debt, meaning that it will operate on a debt-free basis, improving cash flow. The fundraising also will support the restructuring of MySale into an Australia and New Zealand-focused retail marketplace platform - what it calls its "ANZ First" strategy. Some 79% of MySale shareholders have supported the placing of 500.0 million shares at a price of 2.0 pence each. The placing price represents a discount of 58% to the closing price of 4.75 pence on Monday. Looking forward, MySale proposed an open offer for up to a further GBP2.0 million to be launched in due course.----------

More News
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more
22 Sep 2023 07:27

AstraZeneca reports positive findings from breast cancer threatment trial

(Sharecast News) - New high-level results from AstraZeneca's TROPION-Breast01 phase three trial, released on Friday, carried encouraging news for patients with inoperable or metastatic hormone receptor (HR)-positive, HER2-low or negative breast cancer.

Read more
20 Sep 2023 08:44

TOP NEWS: AstraZeneca's rare disease business buys Pfizer portfolio

(Alliance News) - AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.

Read more
15 Sep 2023 15:27

AstraZeneca and Daiichi Sankyo's Enhertu recommended for approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd's Enhertu has been recommended for approval in the EU on Friday.

Read more
14 Sep 2023 08:25

Smith & Nephew brings BT Chief Financial Officer Simon Lowth to board

(Alliance News) - Smith & Nephew PLC on Thursday announced that BT Group PLC's chief financial officer, Simon Lowth, will join the board as independent non-executive director on January 1.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.